Home Overview Press Room Blog Publications For Students about us
Search

US Federal : Displaying 11-20 of 1232


UC Davis professor wants FDA to create firm guidelines for stem-cell treatments, put clinics on noticeby Claudia BuckSacramento BeeDecember 24th, 2016Now is the time for the U.S. Food and Drug Administration to finalize guidelines and send notices to clinics that are offering untested treatments.
Why tech offers better fertility benefits than other industries[cites CGS's Marcy Darnovsky]by Alison DeNiscoTech RepublicDecember 21st, 2016The benefits are part of the current talent war for engineers and other professionals. Tech workers should be cautious about using the procedures.
Obama’s Outgoing Science Advisor Will Keep Watch in 2017by Dave LevitanWIREDDecember 20th, 2016There is no denying the scientific know-how of the outgoing administration. What comes next has scientists worried.
Bioterrorism And Gene Editing: Can Crispr Tool Be Used As Biological Weapon In War?by Himanshu GoenkaIB TimesDecember 14th, 2016Given its broad distribution, low cost, and accelerated pace of development, deliberate or unintentional misuse of gene editing might have far-reaching economic and national security implications.
We Launched a New Website! Surrogacy360by Kiki Zeldes, Biopolitical Times guest contributorDecember 14th, 2016Surrogacy360 provides accurate information and resources, free of commercial interest, for people considering surrogacy outside the United States.
Biopolitical News of 2016by Pete Shanks, Leah Lowthorp & Marcy DarnovskyBiopolitical TimesDecember 13th, 2016We highlight 2016’s trends in and top news stories about human biotech developments.
Slippery Slopes and Biological Curve Balls: Updates on 3-person IVFby Leah LowthorpBiopolitical TimesDecember 13th, 2016There have been several recent setbacks and troubling developments in 3-person IVF technology and applications.
With 21st Century Cures Act, the Future of Regenerative Medicine Is “Inject and See”by Megan MoltenWiredDecember 13th, 2016Critics say it’s deregulation in sheep’s clothing — and worry that both science and patients will suffer.
Trump is considering a radical to lead FDA. That’s dangerous for public healthby Ed SilvermanSTATDecember 12th, 2016Imagine being prescribed a medicine when no one has a clue if it will work — because the government never required it to be tested for effectiveness.
Historians seek reparations for Californians forcibly sterilizedby Ronnie CohenReuters HealthDecember 12th, 2016Alexandra Stern and colleagues investigated over 20,000 documents from the state's eugenics program. Many victims are alive today; California, like other states, should offer them financial compensation.
Displaying 11-20 of 1232  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760